Skip to main content

Preservation of Fertility in the Cancer Patient

  • Chapter
  • First Online:
Side Effects of Medical Cancer Therapy
  • 965 Accesses

Abstract

Preservation of fertility is a key determinant of long-term quality of life of adolescents and young adults treated for curable forms of cancer. The risk of developing primary or secondary infertility after completion of their treatment is variable and difficult to predict. Moreover, evaluation of the extent and reversibility of gonadotoxicity of cancer therapies is currently imperfect, especially in young women.

The term oncofertility was originally coined to describe a new discipline that bridges oncology and reproductive medicine to discover and apply new fertility preservation (FP) options for young patients with cancer. Although there is a great interest in this field, due to the lack of large prospective cohort studies and randomized trials, the level of evidence is higher than III for most of the recommendations.

The most established methods of preserving fertility are sperm banking in men and embryo/oocyte cryopreservation in young women. However, many alternative options, though still experimental, are in development that can already be proposed to young patients in well-defined conditions.

Despite the progress and refinement of FP techniques and the increase in educational resources, an information gap between patients and healthcare teams still persists. Concerted efforts must be made in parallel and global oncofertility programs developed to offer high-quality techniques to meet this unique need in young patients with cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 109.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 139.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 199.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Knopman JM, Papadopoulos EB, Grifo JA, Fino ME, Noyes N. Surviving childhood and reproductive-age malignancy: effects on fertility and future parenthood. Lancet Oncol. 2010;11(5):490–8.

    Article  PubMed  Google Scholar 

  2. Levine J, Canada A, Stern CJ. Fertility preservation in adolescents and young adults with cancer. J Clin Oncol. 2010;28(32):4831–41.

    Article  PubMed  Google Scholar 

  3. Kelvin JF, Thom B, Benedict C, Carter J, Corcoran S, Dickler MN, et al. Cancer and fertility program improves patient satisfaction with information received. J Clin Oncol. 2016;34(15):1780–6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Jeruss JS, Woodruff TK. Preservation of fertility in patients with cancer. N Engl J Med. 2009;360(9):902–11.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Peate M, Meiser B, Friedlander M, Zorbas H, Rovelli S, Sansom-Daly U, et al. It’s now or never: fertility-related knowledge, decision-making preferences, and treatment intentions in young women with breast cancer – an Australian fertility decision aid collaborative group study. J Clin Oncol. 2011;29(13):1670–7.

    Article  PubMed  Google Scholar 

  6. Katz DJ, Kolon TF, Feldman DR, Mulhall JP. Fertility preservation strategies for male patients with cancer. Nat Rev Urol. 2013;10(8):463–72.

    Article  PubMed  Google Scholar 

  7. Hsiao W, Stahl PJ, Osterberg EC, Nejat E, Palermo GD, Rosenwaks Z, et al. Successful treatment of postchemotherapy azoospermia with microsurgical testicular sperm extraction the Weill Cornell experience. J Clin Oncol. 2011;29(12):1607–11.

    Article  PubMed  Google Scholar 

  8. Stahl O, Boyd HA, Giwercman A, Lindholm M, Jensen A, Kjaer SK, et al. Risk of birth abnormalities in the offspring of men with a history of cancer: a cohort study using Danish and Swedish national registries. J Natl Cancer Inst. 2011;103(5):398–406.

    Article  PubMed  PubMed Central  Google Scholar 

  9. Lambertini M, Del Mastro L, Pescio MC, Andersen CY, Azim HA Jr, Peccatori FA, et al. Cancer and fertility preservation: international recommendations from an expert meeting. BMC Med. 2016;14:1–16.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Sukumvanich P, Case LD, Van Zee K, Singletary SE, Paskett ED, Petrek JA, et al. Incidence and time course of bleeding after long-term amenorrhea after breast cancer treatment: a prospective study. Cancer. 2010;116(13):3102–11.

    Article  PubMed  Google Scholar 

  11. Reh A, Oktem O. Impact of breast cancer chemotherapy on ovarian reserve: a prospective observational analysis by menstrual history and ovarian reserve markers. Fertil Steril. 2008;90(5):1635–9.

    Article  CAS  PubMed  Google Scholar 

  12. Iwase A, Nakamura T, Nakahara T, Goto M, Kikkawa F. Anti-Mullerian hormone and assessment of ovarian reserve after ovarian toxic treatment: a systematic narrative review. Reprod Sci. 2015;22(5):519–26.

    Article  CAS  PubMed  Google Scholar 

  13. Loren AW, Mangu PB, Beck LN, Brennan L, Madgalinsky AJ, Partridge AH, et al. Fertility preservation for patients with cancer: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol. 2013;31(19):2500–10.

    Article  PubMed  PubMed Central  Google Scholar 

  14. Peccatori FA, Azim HA Jr, Orecchia R, Hokestra HJ, Pavlidis N, Kesic V, et al. Cancer, pregnancy and fertility: ESMO clinical practical guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2013;24(Suppl 6):vi160–70.

    Article  PubMed  Google Scholar 

  15. Sönmezer M, Türkçüoğlu I, Coşkun U, Oktay K. Random-start controlled ovarian hyperstimulation for emergency fertility preservation in letrozole cycles. Fertil Steril. 2011;95(6):2125.e9–11.

    Article  CAS  Google Scholar 

  16. Oktay K, Turan V, Bedoschi G, Pacheco FS, Moy F. Fertility preservation success subsequent to concurrent aromatase inhibitor treatment as ovarian stimulation in woman with breast cancer. J Clin Oncol. 2015;33(22):2424–9.

    Article  PubMed  PubMed Central  Google Scholar 

  17. Azim AA, Costantini-Ferrando M, Oktay K. Safety of fertility preservation by ovarian stimulation with letrozole and gonadotropins in patients with breast cancer: a prospective controlled study. J Clin Oncol. 2008;26(16):2630–5.

    Article  CAS  PubMed  Google Scholar 

  18. Goldrat O, Kroman N, Peccatori FA, Cordoba O, Pistilli B, Lidegaard O, et al. Pregnancy following breast cancer using assisted reproduction and its effect on long-term outcome. Eur J Cancer. 2015;51(12):1490–6.

    Article  PubMed  Google Scholar 

  19. Donnez J, Dolamnm M. Fertility preservation in women. N Engl J Med. 2017;377:1657–65.

    Article  PubMed  Google Scholar 

  20. Donnez J, Dolmans M-M, Pellicer A, Diaz-Garcia C, Ernst E, Macklon KT, et al. Fertility preservation for age-related fertility decline. Lancet. 2015;385(9967):506–7.

    Article  PubMed  Google Scholar 

  21. Andersen CY. Success and challenges in fertility preservation after ovarian tissue grafting. Lancet. 2015;6/8(9981):1947–8.

    Article  Google Scholar 

  22. Dolmans MM, Marinescu C, Saussoy P, Van Langendonckt A, Amorim C, Donnez J. Reimplantation of cryopreserved ovarian tissue from patients with acute lymphoblastic leukemia is potentially unsafe. Blood. 2010;116(16):2908–14.

    Article  CAS  PubMed  Google Scholar 

  23. Rosendahl M, Timmermans Wielenga V, Nedergaard L, Kristensen SG, Ernst E, et al. Cryopreservation of ovarian tissue for fertility preservation: no evidence of malignant cell contamination in ovarian tissue from patients with breast cancer. Fertil Steril. 2011;95(6):2158–61.

    Article  PubMed  Google Scholar 

  24. Moore HCF, Unger JM, Phillips K-A, Boyle F, Hitre E, Porter D, et al. Goserelin for ovarian protection during breast cancer adjuvant chemotherapy. N Engl J Med. 2015;372(10):923–32.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Bedaiwy MA, Abou-Setta AM, Desai N, Hurd W, Starks D, El-Nashar SA, et al. Gonadotropin-releasing hormone analog cotreatment for preservation of ovarian function during gonadotoxic chemotherapy: a systematic review and meta-analysis. Fertil Steril. 2011;95(3):906–14.e1–4.

    Article  CAS  Google Scholar 

  26. Lambertini M, Ceppi M, Peccatori FA, Azim HA Jr, Ugolini D, et al. Ovarian suppression using luteinizing hormone-releasing hormone agonists during chemotherapy to preserve ovarian function and fertility of breast cancer patients: a meta-analysis of randomized studies. Ann Oncol. 2015;26(12):2408–19.

    PubMed  CAS  Google Scholar 

  27. Behringer K, Wildt L, Mueller H, Mattle V, Ganitis P, van den Hoonaard B, et al. No protection of the ovarian follicle pool with the use of GnRH-analogues or oral contraceptives in young women treated with escalated BEACOPP for advanced-stage Hodgkin lymphoma. Final results of a phase II trial from the German Hodgkin Study Group. Ann Oncol. 2010;21(10):2052–60.

    Article  CAS  PubMed  Google Scholar 

  28. Demeestere I, Brice P, Fedro A, Peccatori FA, Kentos A, Dupuis J, Zachee P, et al. No evidence for the benefit of the gonadotropin-releasing hormone agonist in preserving ovarian function and fertility in lymphoma survivors treated with chemotherapy: final long – term report of a prospective randomized trial. J Clin Oncol. 2016;34(22):2568–74.

    Article  CAS  PubMed  Google Scholar 

  29. Quinn GP, Vadaparampil ST, Lee JH, Jacobsen PB, Bepler G, Lancaster J, et al. Physician referral for fertility preservation in oncology patients: a national study of practice behaviors. J Clin Oncol. 2009;27(35):5952–7.

    Article  PubMed  Google Scholar 

  30. Quinn GP, Vadaparampil ST, Malo T, Reinecke J, Bower B, Albrecht T, et al. Oncologists’ use of patient educational materials about cancer and fertility preservation. Psychooncology. 2012;21(11):1244–9. https://doi.org/10.1002/pon.2022.

    Article  PubMed  Google Scholar 

  31. Letourneau JM, Ebbel EE, Katz PP, Katz A, Ai WZ, Chien AJ, et al. Pretreatment fertility counseling and fertility preservation improve quality of life in reproductive age women with cancer. Cancer. 2011;118(6):1710–7. https://doi.org/10.1002/cncr.26459.

    Article  PubMed  PubMed Central  Google Scholar 

  32. Azim HA Jr, Santoro L, Pavlidis N, Gelber S, Kroman N, Azim H, et al. Safety of pregnancy following breast cancer diagnosis: a meta-analysis of 14 studies. Eur J Cancer. 2011;47(1):74–83.

    Article  PubMed  Google Scholar 

  33. Azim HA Jr, Kroman N, Paesmans M, Gelber S, Rotmensz N, Ameyne L, et al. Prognostic impact of pregnancy after breast cancer according to estrogen receptor status: a multicenter retrospective study. J Clin Oncol. 2013;31(1):73–9.

    Article  PubMed  Google Scholar 

  34. Fournier EM. Oncofertility and the rights to future fertility. JAMA Oncol. 2016;2(2):249–52.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Duhem Caroline .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing AG, part of Springer Nature

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Caroline, D., Ries, F. (2018). Preservation of Fertility in the Cancer Patient. In: Dicato, M., Van Cutsem, E. (eds) Side Effects of Medical Cancer Therapy. Springer, Cham. https://doi.org/10.1007/978-3-319-70253-7_13

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-70253-7_13

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-70252-0

  • Online ISBN: 978-3-319-70253-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics